ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jun 4, 2013
ASCO Reveals That Big Pharma Is Alive
Some good news from Bristol-Myers Squibb, Merck, GlaxoSmithKline, and Amgen showed the promise of immunotherapies for cancer treatment.
Jun 3, 2013
Look Out Below: Iron Ore Prices Keep Falling
With China’s economy “struggling,” iron ore prices will remain weak. Let’s take a look at how the miners intend to handle the situation.
May 30, 2013
Astronics Acquires Peco to Get Closer to Boeing
Best Ideas Newsletter holding Astronics acquired Peco for $136 million.
May 10, 2013
Best Ideas Newsletter Portfolio Holding Precision Castparts Posts Blockbuster Fourth Quarter Results; Shares Soar
Best Ideas Newsletter Portfolio holding Precision Castparts posted a tremendous fourth quarter. Shares hit a fresh all-time high.
May 7, 2013
Taking a Close Look at Berkshire
After the annual meeting in Omaha, let’s take a look at Berkshire.
Jan 29, 2013
Record Performance in 2012 at Caterpillar
Let's dig into Caterpillar's fourth-quarter results and economic outlook for 2013.
Jan 26, 2013
Making Another Call on Precision Castparts; Raising Our Fair Value Estimate Materially
Precision Castparts announced solid fiscal third-quarter results and offered its estimate for synergies related to the Titanium Metals deal. We expect management to deliver in a big way.
Jan 18, 2013
Strong Holiday Sales Boost Toy Makers
NPD is out with holiday sales numbers that were solid, in our view. Let’s take a look at the toy industry.
Jan 3, 2013
No Coal? No Problem for the Rails
In spite of waning demand for coal and metallic ores, rail traffic remains strong.
Jan 2, 2013
Fiscal Cliff Averted; Aerospace Rallying
EDAC, Astronics, and Precision Castparts -- three of our favorite companies in aerospace -- are surging!


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.